Volume 33, Issue 220 (5-2023)
J Mazandaran Univ Med Sci 2023, 33(220): 150-157 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Alizadeh-Navaei R, Hedayatizadeh-Omran A, Zaboli E, Khazaee M, Amjadi O, Omrani-Nava V et al . Total IgE Level in the Peripheral Blood of Patients with
Breast Cancer. J Mazandaran Univ Med Sci 2023; 33 (220) :150-157
URL: http://jmums.mazums.ac.ir/article-1-19038-en.html
URL: http://jmums.mazums.ac.ir/article-1-19038-en.html
Reza Alizadeh-Navaei 
, Akbar Hedayatizadeh-Omran , Ehsan Zaboli , Mohadeseh Khazaee , Omolbanin Amjadi , Versa Omrani-Nava , Motahareh Kheradmand
, Akbar Hedayatizadeh-Omran , Ehsan Zaboli , Mohadeseh Khazaee , Omolbanin Amjadi , Versa Omrani-Nava , Motahareh Kheradmand
Abstract: (883 Views)
Background and purpose: Breast cancer is one of the most common cancers and the first cause of cancer-related deaths in women. Evidence suggests that allergies may be associated with cancer progression. Immunoglobulin E as part of the allergic immune response plays a role in the occurrence of type 1 hypersensitivity responses and allergic diseases such as asthma, allergies, allergic rhinitis, and probably cancers.
Materials and methods: We carried out a cross-sectional study in breast cancer patients as a case group and people without cancer as a control group. Total IgE level in the groups was measured by ELISA method using the monoset kit by Calbiotech (USA). Data, including total IgE level and eosinophil percentage of the patients along with participans’ age were recorded in excel. Data analysis was done in SPSS V19 using T-test, Mann-Whitney and partial correlation.
Results: In this study, 160 patients were examined. The mean ages of patients in the case group and control group were 48.18±10.49 years and 41.68±7.95 years, respectively. There was a significant difference between the two groups in mean age (P<0.001). IgE level was not found to be significantly different between the two groups (P=0.92). Findings revealed no significant difference in eosinophil percentage between breast cancer patients and healthy patients (P=0.82). We observed no significant correlation between age and IgE levels (r=-0.043, P=0.594) and eosinophil percentage (r=0.145, P=0.068) after control for groups.
Conclusion: This study showed that the levels of IgE and the percentage of eosinophils in the peripheral blood cannot be not considered as a predictive factor in the diagnosis of breast cancer.
Materials and methods: We carried out a cross-sectional study in breast cancer patients as a case group and people without cancer as a control group. Total IgE level in the groups was measured by ELISA method using the monoset kit by Calbiotech (USA). Data, including total IgE level and eosinophil percentage of the patients along with participans’ age were recorded in excel. Data analysis was done in SPSS V19 using T-test, Mann-Whitney and partial correlation.
Results: In this study, 160 patients were examined. The mean ages of patients in the case group and control group were 48.18±10.49 years and 41.68±7.95 years, respectively. There was a significant difference between the two groups in mean age (P<0.001). IgE level was not found to be significantly different between the two groups (P=0.92). Findings revealed no significant difference in eosinophil percentage between breast cancer patients and healthy patients (P=0.82). We observed no significant correlation between age and IgE levels (r=-0.043, P=0.594) and eosinophil percentage (r=0.145, P=0.068) after control for groups.
Conclusion: This study showed that the levels of IgE and the percentage of eosinophils in the peripheral blood cannot be not considered as a predictive factor in the diagnosis of breast cancer.
Type of Study: Research(Original) |
Subject:
Hematology and Oncology
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
